-
Recro Pharma Announces Pricing of Public Offering of Common Stock
-
Notable Analyst Rating Changes 8/29: (CBL) (ATI) (KS) Upgraded; (HAYN) (KEY) (SQ) Downgraded
-
Janney Montgomery Scott Starts Recro Pharma (REPH) at Buy
-
Recro Pharma Announces Closing of Public Offering of Common Stock
-
Recro Pharma (REPH) Prices 1.99M Common Stock Offering at $7.50/Share
-
Recro Pharma Announces Pricing of Public Offering of Common Stock
-
Recro Pharma (REPH) to Offer Shares of Common Stock
-
Recro Pharma Announces Proposed Public Offering of Common Stock
-
Recro Pharma Completes $16 Million Private Financing

